Explore All Access
Check if your research matches the topics covered in European Oncology and Haematology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
European Oncology and Haematology : Impact Factor & More
eISSN: 2045-5283pISSN: 2045-5275
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
European Oncology and Haematology Key Metrics
CiteScore 
0.5
H-Index
8
SJR
Q4Oncology
SNIP
0.12
European Oncology and Haematology Journal Specifications
| Overview | |
| Publisher | Touch Digital Media |
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in European Oncology and Haematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Oncology and Haematology
Immunotherapy in Advanced Prostate Cancer
- 1 Jan 2020
- European Oncology & Haematology
ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases
- 1 Jan 2020
- European Oncology & Haematology
Development of<i>HER2</i>-targeted Therapies for Gastrointestinal Cancer
- 1 Jan 2020
- European Oncology & Haematology
Thromboprophylaxis – A Neglected Front in Hospitalised Patients with COVID-19 in Pakistan
- 1 Jan 2020
- European Oncology & Haematology
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
- 1 Jan 2020
- European Oncology & Haematology
Regorafenib – Five Years in Review
- 1 Jan 2020
- European Oncology & Haematology
Immunotherapy in Advanced Prostate Cancer
- 1 Jan 2020
- European Oncology & Haematology
ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases
- 1 Jan 2020
- European Oncology & Haematology
Development of<i>HER2</i>-targeted Therapies for Gastrointestinal Cancer
- 1 Jan 2020
- European Oncology & Haematology
Thromboprophylaxis – A Neglected Front in Hospitalised Patients with COVID-19 in Pakistan
- 1 Jan 2020
- European Oncology & Haematology
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
- 1 Jan 2020
- European Oncology & Haematology
Regorafenib – Five Years in Review
- 1 Jan 2020
- European Oncology & Haematology
FAQs on European Oncology and Haematology
How many articles did European Oncology and Haematology publish last year? 
In 2023, European Oncology and Haematology publsihed undefined articles.
What is the eISSN & pISSN for European Oncology and Haematology?
For European Oncology and Haematology, eISSN is 2045-5283 and pISSN is 2045-5275.
What is Citescore for European Oncology and Haematology?
Citescore for European Oncology and Haematology is 0.5.
What is the H Index for European Oncology and Haematology ?
H Index for European Oncology and Haematology is 8.
What is SNIP score for European Oncology and Haematology?
SNIP score for European Oncology and Haematology is 0.12.
What is the SJR for European Oncology and Haematology?
SJR for European Oncology and Haematology is Q4.
Who is the publisher of European Oncology and Haematology?
Touch Digital Media is the publisher of European Oncology and Haematology.